重组单克隆抗体生物类似药质量研究的一般考虑
General Considerations of Quality Study for Biosimilar Products Containing Recombinant Monoclonal Antibodies
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|